Partnerships

Connected and Automated Mobility (CCAM)

Connected and Automated Mobility (CCAM)

Partnership website: https://www.ccam.eu/

The CCAM co-programmed partnership aims to accelerate the implementation of innovative, connected, cooperative and automated mobility (CCAM) technologies and services in Europe.

The partnership aims to accelerate the implementation of innovative, connected, cooperative and automated mobility (CCAM) through the following three goals:

  • The goal of CCAM is to create a more user-centered and inclusive mobility system, increasing road safety while reducing congestion and environmental footprint.
  • More collaborative research, testing and demonstration projects in order to accelerate the innovation pace and implementation of automated mobility.
  • Working together at European level to help remove barriers and contribute to the acceptance and efficient rollout of automation technologies and services.

By 2030, the partnership aims to have demonstrated inclusive, user-oriented and well-integrated mobility concepts with increased safety and a reduced carbon footprint. I

The CCAM Partnership's activities are structured around 7 clusters, organising the R&I actions by aligning deployment readiness with road users and operators, policy-makers, and industry:

  1. Large-scale demonstration
  2. Vehicle technologies
  3. Validation
  4. Integrating CCAM in the transport system
  5. Key Enabling Technologies
  6. Societal Aspects and People Needs
  7. Coordination

As a co-programmed partnership, the CCAM call topics are integrated in the regular Horizon Europe cluster 5 work programme. These topics contribute to achieving the objectives of this co-programmed partnership.

Key documents

Contact

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

More detailed info Overview of partnerships

How to use partnerships?

  • orientation
    Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
  • networking
    Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
  • ecosystem analysis
    Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
  • steering the agenda
    Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Author Do you have an additional question? Or spotted a mistake? Don't hesitate to contact me!
Image of Pascal Verheye
Pascal Verheye

pascal.verheye@vlaio.be

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article Check out the other testimonials 
Logo of VLAIO
Logo of FWO

NCP Flanders

Updates

Our Services

Legal mentions

Privacy Policy
Cookies

LinkedIn